Literature DB >> 1904353

The changes of interleukin-2, tumour necrotic factor and gamma-interferon production among patients with Kawasaki disease.

C Y Lin1, C C Lin, B Hwang, B N Chiang.   

Abstract

Included in this study were 43 cases of mucocutaneous lymph node syndrome (MCLS or Kawasaki disease) treated solely with aspirin. Of these, 19 developed coronary aneurysm. Mononuclear cells (MNC) of these MCLS patients were collected weekly and stimulated either with phytohaemagglutinin (PHA) or PHA plus phorbol myristic acetate. The production of interleukin-2 (IL-2), tumour necrotic factor (TNF) and gamma-interferon (IFN-r) was determined. In addition, IL-2, TNF, IFN-r from serial collections of serum samples of these patients were also measured. The results show that serum IL-2 and TNF were detected in the 1st week, reached maximal plateau in the 2nd and 3rd week and decreased 1 month later. The production of IL-2, TNF and IFN-r from MCLS patients' MNC increased from the 1st to the 3rd week, persisted at a high level for 1 month and then decreased. During the 2nd and 3rd weeks, there were significantly higher serum IL-2 levels and IL-2 production in patients with than in patients without coronary lesions. These observations suggest that the serum IL-2 level and IL-2 production during the 2nd week may serve as a predictive parameter for coronary aneurysm formation. It also suggests that the production of TNF, IL-2 and IFN-r from MNC may contribute to the development of vascular injury in acute MCLS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1904353     DOI: 10.1007/bf01963561

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

1.  Kawasaki disease: cardiac problems and management.

Authors:  H Kato; O Inoue; T Akagi
Journal:  Pediatr Rev       Date:  1988-01

2.  Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome.

Authors:  D Y Leung; E T Chu; N Wood; S Grady; R Meade; R S Geha
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

3.  Immunoregulatory abnormalities in mucocutaneous lymph node syndrome.

Authors:  D Y Leung; R L Siegel; S Grady; A Krensky; R Meade; E L Reinherz; R S Geha
Journal:  Clin Immunol Immunopathol       Date:  1982-04

4.  A comparative study on the immunological effects of bovine and porcine thymic extracts: induction of lymphoproliferative response and enhancement of interleukin-2, gamma-interferon and tumor necrotic factor production in vitro on cord blood lymphocytes.

Authors:  C Y Lin; T L Low
Journal:  Immunopharmacology       Date:  1989 Jul-Aug

Review 5.  Cachectin and tumour necrosis factor as two sides of the same biological coin.

Authors:  B Beutler; A Cerami
Journal:  Nature       Date:  1986 Apr 17-23       Impact factor: 49.962

6.  Enhancement of interleukin-2 and gamma-interferon production in vitro on cord blood lymphocytes and in vivo on primary cellular immunodeficiency patients with thymic extract (thymostimulin).

Authors:  C Y Lin; Y C Kuo; C C Lin; B R Ou
Journal:  J Clin Immunol       Date:  1988-03       Impact factor: 8.317

7.  Serial immunologic studies in patients with mucocutaneous lymph node syndrome (Kawasaki disease).

Authors:  C Y Lin; B Hwang
Journal:  Ann Allergy       Date:  1987-10

8.  Nationwide survey on Kawasaki disease in Japan.

Authors:  H Yanagawa; T Kawasaki; I Shigematsu
Journal:  Pediatrics       Date:  1987-07       Impact factor: 7.124

9.  Interleukin 2: the molecule and its function.

Authors:  R J Robb
Journal:  Immunol Today       Date:  1984-07

10.  Pathology of the heart in Kawasaki disease.

Authors:  H Fujiwara; Y Hamashima
Journal:  Pediatrics       Date:  1978-01       Impact factor: 7.124

View more
  14 in total

1.  Th1 and Th2 cytokine production is suppressed at the level of transcriptional regulation in Kawasaki disease.

Authors:  J Kimura; H Takada; A Nomura; T Ohno; Y Mizuno; M Saito; K Kusuhara; T Hara
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

2.  The contribution of tumour necrosis factor-alpha and endothelin-1 to the increase of coronary resistance in hearts from rats treated with endotoxin.

Authors:  T Hohlfeld; P Klemm; C Thiemermann; T D Warner; K Schrör; J R Vane
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

3.  Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1 beta by peripheral blood monocytes in the acute phase of Kawasaki disease.

Authors:  H Suzuki; S Uemura; S Tone; T Iizuka; M Koike; K Hirayama; J Maeda
Journal:  Eur J Pediatr       Date:  1996-04       Impact factor: 3.183

4.  Association of IL-1Ra gene polymorphism, but no association of IL-1beta and IL-4 gene polymorphisms, with Kawasaki disease.

Authors:  Shu-Fen Wu; Jeng-Sheng Chang; Lei Wan; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

5.  Association of vascular endothelial growth factor C-634 g polymorphism in taiwanese children with Kawasaki disease.

Authors:  K-C Hsueh; Y-J Lin; J-S Chang; L Wan; Y-H Tsai; C-H Tsai; C-P Chen; F-J Tsai
Journal:  Pediatr Cardiol       Date:  2007-09-15       Impact factor: 1.655

6.  Cytokines predict coronary aneurysm formation in Kawasaki disease patients.

Authors:  C Y Lin; C C Lin; B Hwang; B N Chiang
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

7.  A functional polymorphism, rs28493229, in ITPKC and risk of Kawasaki disease: an integrated meta-analysis.

Authors:  Jiao Lou; Sanqing Xu; Li Zou; Rong Zhong; Ti Zhang; Yu Sun; Xuzai Lu; Li Liu; Chuanqi Li; Li Wang; Guanglian Xiong; Wei Wang; Fangqi Gong; Jing Wu
Journal:  Mol Biol Rep       Date:  2012-10-13       Impact factor: 2.316

8.  Superantigen involvement and susceptibility factors in Kawasaki disease: profiles of TCR Vβ2+ T cells and HLA-DRB1, TNF-α and ITPKC genes among Filipino patients.

Authors:  Magdalena F Natividad; Celia Aurora T Torres-Villanueva; Cynthia P Saloma
Journal:  Int J Mol Epidemiol Genet       Date:  2013-03-18

9.  Elevated Serum Levels of IL-21 in Kawasaki Disease.

Authors:  Yon Jung Bae; Mi Hyun Kim; Hae Yong Lee; Young Uh; Mee Kyung Namgoong; Byung Ho Cha; Jin-Kyong Chun
Journal:  Allergy Asthma Immunol Res       Date:  2012-06-29       Impact factor: 5.764

10.  Concurrent adrenal neuroblastoma and kawasaki disease: a report of a rare case.

Authors:  Samin Alavi; Alireza Fahimzad; Farzaneh Jadali; Farid Ghazizadeh; Armin Rashidi
Journal:  Case Rep Pediatr       Date:  2013-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.